Literature DB >> 16313361

Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein.

Christine M Gockel1, Michael W Russell.   

Abstract

Previous reports have suggested that peroral delivery of antigens chemically coupled to non-toxic recombinant enterotoxin B subunits, such as the cholera toxin B subunit (CTB), induces tolerance to the antigen that may be abrogated by the toxic enzyme activity of intact enterotoxins, such as cholera toxin (CT). The aim of this study was to examine the immunogenicity of a genetically coupled protein composed of the saliva-binding region (SBR) of the Streptococcus mutans surface antigen AgI/II and the non-toxic A2 and B subunits of CT (SBR-CTA2/B) compared with that of recombinant SBR admixed with CT (SBR + CT) and SBR chemically coupled to recombinant CTB (SBR-CTB) following peroral delivery by intragastric (i.g.) immunization. The results showed that i.g. immunization with SBR-CTA2/B, like SBR + CT, induced antigen-specific serum immunoglobulin G (IgG) and salivary IgA antibodies, and sensitized splenic T cells. Comparison studies with SBR-CTB produced serum IgG but not salivary IgA titres and failed to sensitize splenic cells. Immunization with SBR-CTA2/B via the intranasal route also primed for the recall of antigen-specific memory antibody responses 6 months later. These findings show that SBR-CTA2/B is an immunogenic, not tolerogenic, chimeric protein that can induce and recall antigen-specific memory responses upon mucosal immunization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16313361      PMCID: PMC1802434          DOI: 10.1111/j.1365-2567.2005.02246.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  52 in total

1.  Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.

Authors:  M W Russell; H Y Wu
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

2.  Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin.

Authors:  A D Wilson; C J Clarke; C R Stokes
Journal:  Scand J Immunol       Date:  1990-04       Impact factor: 3.487

3.  Oral tolerance to ovalbumin in mice: studies of chemically modified and 'biologically filtered' antigen.

Authors:  M G Bruce; A Ferguson
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

4.  Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.

Authors:  C Czerkinsky; M W Russell; N Lycke; M Lindblad; J Holmgren
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

5.  Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin.

Authors:  S D Miller; D G Hanson
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

6.  Plasmid vectors for constructing translational fusions to the B subunit of cholera toxin.

Authors:  M T Dertzbaugh; F L Macrina
Journal:  Gene       Date:  1989-10-30       Impact factor: 3.688

7.  Detection and specificity of antibodies secreted by spleen cells in mice immunized with Streptococcus mutans.

Authors:  M W Russell; C Czerkinsky; Z Moldoveanu
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

8.  The B subunit of Escherichia coli heat labile enterotoxin abrogates oral tolerance, promoting predominantly Th2-type immune responses.

Authors:  Andrea Plant; Rachel Williams; Michelle E Jackson; Neil A Williams
Journal:  Eur J Immunol       Date:  2003-11       Impact factor: 5.532

9.  The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity.

Authors:  N Lycke; T Tsuji; J Holmgren
Journal:  Eur J Immunol       Date:  1992-09       Impact factor: 5.532

10.  Systemic tolerance and secretory immunity after oral immunization.

Authors:  S J Challacombe; T B Tomasi
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  7 in total

1.  Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.

Authors:  Juliette K Tinker; Chadwick T Davis; Britni M Arlian
Journal:  Protein Expr Purif       Date:  2010-05-11       Impact factor: 1.650

2.  Mucosal immunization with a Staphylococcus aureus IsdA-cholera toxin A2/B chimera induces antigen-specific Th2-type responses in mice.

Authors:  Britni M Arlian; Juliette K Tinker
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

3.  Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activation.

Authors:  Qingan Xu; Jenny Katz; Ping Zhang; Amit R Ashtekar; Dalia E Gaddis; Mingwen Fan; Suzanne M Michalek
Journal:  Infect Immun       Date:  2011-07-11       Impact factor: 3.441

4.  Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometry.

Authors:  Weiwei Zhao; Hans Minderman; Michael W Russell
Journal:  Clin Vaccine Immunol       Date:  2013-11-06

5.  Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins.

Authors:  W Zhao; Z Zhao; M W Russell
Journal:  Mol Oral Microbiol       Date:  2011-03-31       Impact factor: 3.563

6.  Loss of sialic acid binding domain redirects protein σ1 to enhance M cell-directed vaccination.

Authors:  Dagmara Zlotkowska; Massimo Maddaloni; Carol Riccardi; Nancy Walters; Kathryn Holderness; Gayle Callis; Agnieszka Rynda-Apple; David W Pascual
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

7.  Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.

Authors:  Juliette K Tinker; Jie Yan; Reece J Knippel; Panos Panayiotou; Kenneth A Cornell
Journal:  Toxins (Basel)       Date:  2014-04-22       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.